The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations SINGAPORE, ...

Singapore, Singapore--(Newsfile Corp. - September 15, 2024) - XinKailian Biotechnology, a prominent player in the nutraceutical industry ... appearance at Vitafoods Asia 2024.

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

The advanced RNA therapeutics manufacturing company will address growing demand for RNA therapeutics in the Asia-Pacific region ... Unfettered access to industry-leading news, commentary and analysis ...

Charles River, which provides contract research services to biotech and pharmaceutical companies ... and various other locations in Europe and Asia. Founded in Boston in 1947, Charles River ...

The country is experiencing rapid growth in biotechnology thanks to continuous public and private sector investment and ... to expand their presence in Asia. The country's proximity to major ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

Ex-Novozymes exec Peter Rosholm has acquired the assets of bankrupt biomanufacturing startups Solar Biotech and Noblegen.

Despite heightened political tensions, both Chinese and U.S. industry officials are working to strengthen ties in the health ...

Find out more about six immunology companies that have recently raised impressive funds in the biotech industry.

Starting as a spinoff from a bigger company, Inhibrx's route in the biotech sector might be uniquely carved out. Unlike larger businesses hampered by bureaucracy, Inhibrx was born free to create ...